Stop-Gap Spending Bill Provision Takes Aim at Biologics Patent Litigation
By EsqSocial Corporation 20/12/24
UPDATE: The stop-gap spending bill has been revised to remove the provision discussed herein. However, life sciences companies should nonetheless take note of efforts by congress to enact patent-related reforms such as this....
By: MoFo Life Sciences